Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight

0
146
Novo Nordisk’s new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues a bidding war with U.S. rival Pfizer.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here